Government recalls Celogen Pharma pharmaceutical products

Some of them did not meet pharmacopoeial standards.

According to a report, the Department of Health has instructed licensed drug wholesaler Batou Limited to recall all registered pharmaceutical products manufactured by Celogen Pharma in India as some of them have failed to meet pharmacopoeial standards.

Test results showed that samples of three products, namely Celonol 25 Tablets, Celevox 500 Tablets and Melcicam Tablets 7.5mg, exceeded the limit for total bacterial count.

Batou was instructed to recall the three products concerned and, as a precautionary measure, all remaining registered pharmaceutical products available in Hong Kong manufactured by Celogen.

A total of 34 pharmaceutical products manufactured by Celogen are registered in Hong Kong. Among these, 11 products have been imported for local sale and distribution. They have been supplied to private doctors and dispensaries.

All these products are prescription drugs and should only be used under medical supervision. Pharmacies can only sell the drugs under the supervision of a registered pharmacist and upon a doctor's prescription.

Microbial contamination of a pharmaceutical product may not only potentially affect the therapeutic efficacy of the product, but also lead to the risk of infection to the user.

The department has not received any adverse reaction reports related to the use of these products so far.

Call 2781 2619 for enquiries.